These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 6830659

  • 21. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A, Mary-Rabine L, Legrand V, Demoulin JC, Kulbertus HE.
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [Abstract] [Full Text] [Related]

  • 22. Lack of effectiveness of oral mexiletine in patients with drug-refractory paroxysmal sustained ventricular tachycardia. A study utilizing programmed stimulation.
    Palileo EV, Welch W, Hoff J, Strasberg B, Bauernfeind RA, Swiryn S, Coelho A, Rosen KM.
    Am J Cardiol; 1982 Nov; 50(5):1075-81. PubMed ID: 7137034
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
    Waspe LE, Waxman HL, Buxton AE, Josephson ME.
    Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
    [Abstract] [Full Text] [Related]

  • 25. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
    Breithardt G, Seipel L, Abendroth RR, Loogen F.
    Eur Heart J; 1980 Feb; 1(1):11-24. PubMed ID: 7026245
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA, Wu D, Mautner RK, Sherman RH, Ehsani AI, Rosen KM.
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP.
    Acta Cardiol Suppl; 1980 May; (25):121-5. PubMed ID: 6990664
    [Abstract] [Full Text] [Related]

  • 33. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA, Murdock CJ, Boone J, Kerr CR.
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intravenous mexiletine in management of lidocaine-resistant ventricular tachycardia.
    Santinelli V, Chiariello M, Stanislao M, Condorelli M.
    Am Heart J; 1983 Apr; 105(4):680-5. PubMed ID: 6837421
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.